Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,928
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Dallas TX, Fort Worth TX, Oklahoma City OK,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Dallas TX, Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase1, Phase2, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Location: Plano TX, Dallas TX, Fort Worth TX, Tyler TX,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Dallas TX, Houston TX, Jackson MS, Kansas City MO,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Dallas TX, Shreveport LA, Oklahoma City OK, Austin TX,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Dallas TX, Arlington TX, Fort Worth TX, Georgetown TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase2, Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Location: Dallas TX, Fairway KS, Atlanta GA, Chicago IL,
Sponsor: Beat AML, LLC
Sex: All
Age: 18+
Code: NCT03013998
Phase2, Phase3, Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Dallas TX, Fort Worth TX, Tyler TX, Houston TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase1, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Dallas TX, Houston TX, Amarillo TX, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Dallas TX, Flower Mound TX, Fort Worth TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
for
Venous Thromboembolism (VTE)
Location: Dallas TX, Bellaire TX, Houston TX, San Antonio TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07015905
Phase3, Recruiting
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
for
Hypertension, Obesity
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 55
Code: NCT04838678
Early_phase1, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer